Union Therapeutics starts phase II trial of nasal spray for Covid-19 patients
![Photo: Union Therapeutics / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13397206.ece/ALTERNATES/schema-16_9/doc7i49jf7c4xt15c21lfxu.jpg)
The Danish biotech company Union Therapeutics has enrolled the first patient in its phase II trial of drug candidate niclosamide as a treatment for Covid-19 patients, it reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Danish Covid-19 treatment approved for human trials
For subscribers
EMA to investigate Covid-19 treatment
For subscribers